Treatment, Prevention, and Managing Risk

Managing TYK2 deficiency requires a proactive, highly individualized approach. Because the condition is exceptionally rare and clinical severity varies by genotype, there is no single “standard” treatment plan that fits every patient ^[1][2]. Instead, your medical team will focus on preventing infections, avoiding specific risks, and treating illnesses aggressively when they occur ^[1].

Treating Active Infections

When a patient with TYK2 deficiency gets sick, the goal is to identify the specific germ through cultures and use targeted antimicrobials (antibiotics, antivirals, or antifungals).

• Mycobacterial Infections: If an infection from mycobacteria (like TB, environmental mycobacteria, or the germs in the BCG vaccine) occurs, treatment is highly individualized. It depends on the species, drug susceptibility, and the site of infection ^[1]. Case reports show some patients have required specialized antibiotic therapy for as long as two years to fully clear an infection ^[1].
• Viral Infections: Because the body’s natural antiviral alarm (Interferon) is often weakened, infectious disease specialists may utilize antiviral medications earlier or for longer durations ^[3][4].

Adjunct Therapy: Helping the Body Respond

For certain severe or difficult-to-treat mycobacterial infections, specialists may consider adding adjunct Interferon-gamma (IFN-γ) to the medication regimen ^[5].

Because TYK2-deficient cells can respond to this “master key” signal but cannot produce enough of it on their own ^[6][7], giving IFN-γ as a supplement can sometimes help the immune system fight the bacteria ^[5][7]. This is an individualized, specialist-driven therapy with limited case-based evidence in TYK2 deficiency, not a universal treatment for all patients ^[5].

The Role of Immunoglobulin (IVIG)

You may hear about Intravenous or Subcutaneous Immunoglobulin (IVIG/SCIG), which is a common treatment for many other immune disorders ^[8].

In TYK2 deficiency, IVIG is not an automatic, standard therapy. While some patients develop chronic lung damage (bronchiectasis), lung damage alone does not typically justify IVIG ^[8]. The decision to use immunoglobulin replacement depends on whether your specialist finds that your child has low immunoglobulin levels, poor specific antibody responses to vaccines, or an unmanageable rate of recurrent infections despite antibiotics ^[8].

Vaccine Safety and Strategy (Critical)

Vaccination is one of the most important—and complex—parts of managing TYK2 deficiency. You must review all vaccines with a primary immunodeficiency expert.

Live Vaccines (High Risk - Requires Specialist Clearance)

Live vaccines contain a weakened version of a living virus or bacteria ^[9]. In a patient whose immune system cannot easily control these germs, live vaccines can cause a severe, life-threatening “vaccine-derived” infection ^[10][11].

• BCG (Tuberculosis): This is a major, documented risk. In children with TYK2 deficiency, the BCG vaccine can cause severe, spreading disease (BCGosis) and should be avoided ^[10].
• Other Live Vaccines: Vaccines such as MMR (Measles, Mumps, Rubella), Varicella (Chickenpox), Rotavirus, Oral Polio, and the live nasal flu vaccine (FluMist) are generally avoided or significantly delayed until an expert immunologist confirms the patient’s residual immune function can handle them safely ^[9].

Non-Live Vaccines (Generally Recommended)

Non-live vaccines (also called “killed”, “inactivated”, or mRNA vaccines) do not contain a living germ and cannot cause the disease they are meant to prevent ^[12].

• Routine and Seasonal Shots: Current guidelines strongly recommend that immunocompromised individuals receive updated non-live vaccines, such as the injectable flu shot and COVID-19 mRNA vaccines ^[12]. Note that because of the immune defect, the body’s protective response to these vaccines might be lower than average ^[12].
• Protecting the “Circle”: It is highly recommended that household members stay strictly up to date on their vaccines to create a “cocoon” of protection. However, family members must get specific advice about receiving live vaccines themselves, as they can sometimes shed the virus and pose a risk to the patient ^[12].

Every prevention and treatment decision—from prophylactic antibiotics to daily school or daycare precautions—should be made in close consultation with your specialized immunology team ^[1][2].